Improved Astaxanthin Production with by Application of a Membrane Fusion Protein
Overview
Pharmacology
Authors
Affiliations
Astaxanthin is one of the strongest natural antioxidants and a red pigment occurring in nature. This C40 carotenoid is used in a broad range of applications such as a colorant in the feed industry, an antioxidant in cosmetics or as a supplement in human nutrition. Natural astaxanthin is on the rise and, hence, alternative production systems are needed. The natural carotenoid producer is a potent host for industrial fermentations, such as million-ton scale amino acid production. In , astaxanthin production was established through heterologous overproduction of the cytosolic lycopene cyclase CrtY and the membrane-bound β-carotene hydroxylase and ketolase, CrtZ and CrtW, in previous studies. In this work, further metabolic engineering strategies revealed that the potential of this GRAS organism for astaxanthin production is not fully exploited yet. It was shown that the construction of a fusion protein comprising the membrane-bound β-carotene hydroxylase and ketolase (CrtZ~W) significantly increased astaxanthin production under high glucose concentration. An evaluation of used carbon sources indicated that a combination of glucose and acetate facilitated astaxanthin production. Moreover, additional overproduction of cytosolic carotenogenic enzymes increased the production of this high value compound. Taken together, a seven-fold improvement of astaxanthin production was achieved with 3.1 mg/g CDW of astaxanthin.
Application of valencene and prospects for its production in engineered microorganisms.
Song Y, Liu H, Quax W, Zhang Z, Chen Y, Yang P Front Microbiol. 2024; 15:1444099.
PMID: 39171255 PMC: 11335630. DOI: 10.3389/fmicb.2024.1444099.
Promising non-model microbial cell factories obtained by genome reduction.
Ravagnan G, Schmid J Front Bioeng Biotechnol. 2024; 12:1427248.
PMID: 39161352 PMC: 11330790. DOI: 10.3389/fbioe.2024.1427248.
Biotechnological advances for improving natural pigment production: a state-of-the-art review.
Lyu X, Lyu Y, Yu H, Chen W, Ye L, Yang R Bioresour Bioprocess. 2024; 9(1):8.
PMID: 38647847 PMC: 10992905. DOI: 10.1186/s40643-022-00497-4.
Toward improved terpenoids biosynthesis: strategies to enhance the capabilities of cell factories.
Fordjour E, Mensah E, Hao Y, Yang Y, Liu X, Li Y Bioresour Bioprocess. 2024; 9(1):6.
PMID: 38647812 PMC: 10992668. DOI: 10.1186/s40643-022-00493-8.
Gottl V, Meyer F, Schmitt I, Persicke M, Peters-Wendisch P, Wendisch V Sci Rep. 2024; 14(1):8081.
PMID: 38582923 PMC: 10998873. DOI: 10.1038/s41598-024-58700-9.